Literature DB >> 6259974

Attempts to reactivate bovid herpesvirus-2 in experimentally infected calves.

G Castrucci, F Frigeri, V Cilli, B Tesei, A M Arush, B Pedini, S Ranucci, L Rampichini.   

Abstract

A study was carried out to determine whether bovid herpesvirus-2 (BHV-2) is able to induce a recurrent infection in experimentally infected calves. Twelve calves infected with the virus were treated with dexamethasone (DMS) beginning 69 days after the infection, ie, several weeks after the animals had recovered from the disease and were negative for BHV-2. The stress induced by DMS treatment failed to reactivate the clinical condition or to induce shedding of BHV-2. However, treatment with DMS reactivated a latent infectious bovine rhinotracheitis (IBR) virus infection in all calves previously inoculated with BHV-2, and also in 2 noninoculated controls. The reactivation of IBR virus occurred without any clinical evidence of the disease, but the virus was isolated from nasal and pharyngeal swabbings and from the organs. A proliferative ganglionitis of the trigeminal ganglion was also observed. Because of the interference by IBR virus, this study did not resolve the question as to whether BHV-2 can induce a recurrent infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6259974

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  Reactivation in calves of Bovid herpesvirus 2 latent infection.

Authors:  G Castrucci; M Ferrari; F Frigeri; S Ranucci; V Cilli; B Tesei; L Rampichini
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Bovine Alphaherpesvirus 2 infections in Bavaria: an analysis of the current situation - several years after eradicating Bovine Alphaherpesvirus 1.

Authors:  Stefanie Singer; Bernd Hoffmann; Angela Hafner-Marx; Jürgen Christian; Friederike Forster; Katharina Schneider; Gabriela Knubben-Schweizer; Antonie Neubauer-Juric
Journal:  BMC Vet Res       Date:  2020-05-24       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.